Indraprastha Medical Corporation Ltd

BSE Code : 532150
NSE Symbol : INDRAMEDCO
ISIN : INE681B01017
Industry :HEALTHCARE

Trade Now

Get Quotes

487.65 2.90(0.60%)

Open Price (₹)

484.20

Prev. Close (₹)

484.75

Volume (No’s)

102,287

Market Cap (₹)

4,470.43

Low Price (₹)

481.05

High Price (₹)

495.00 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
25-May-2025	NA	we wish to inform you that Dr. Arum Rai ( DIN: 07159822) has completed his second five year term as Independent director in the company, on 25th May, 2025. Therefore he ceases to be director and member of the Audit Committee & Nomination & Remuneration Committee of the board, at end of the day on 25th may, 2025.
22-May-2025	NA	we hereby inform you that Dr Menaka Guruswamy has completed her tenure viz. first term of five (5) consecutive years on 22nd May 2025 as Independent Director on the Board of directors of the Company. she has opted not to renew her second term as an independent Director hence she ceased to be a director of the company at the end of the day on 22nd May 2025.
16-May-2025	NA	Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve This is to hereby inform you that meting of the Board of Directors of the Company will be held on Friday 16th May 2025 Inter Alia:- 1. to consider and approve the audited financial results for the quarter/year ended 31st march 2025; and 2. to consider and recommend dividend if any on equity shares of the Company for the financial year 2024-25. This is to inform you that the Board of Directors of the company has, at its meeting held on Friday, 16th May, 2025 (i.e., Today), inter-alia: 1. Approved the Audited Financial Statements for the year ended 31st March,2025, and Audited Financial Results for the quarter/year ended 31st March, 2025, as recommended by the audit Committee; and, 2. Recommended a dividend @ 45% that is Rs 4.50 per share for the financial year 2024-2025. (As Per BSE Announcement Dated on: 16/05/2025)
31-Mar-2025	NA	The Board Recommended a dividend @ 45% i.e. Rs. 4.50 per share for the financial year 2024-25.
03-Feb-2025	NA	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve Meeting of the Board of the Directors of the company will be held on Monday 3rd February 2025 to consider and approve the un-audited financial results for the quarter ended 31th December 2024. The board of Director of the company has, as its meeting held on Monday, 3rd February, 2025, inter-alia, considered and approved the Un-audited Financial Results of the company for the quarter & nine months ended 31st December, 2024, along with Limited Review Report of the Statutory auditors. We are enclosing herewith un-audited financial results along with limited review report. (As Per BSE Announcement dated on 03.02.2025)